Crossmark

The IL-17 pathway mediated by m6A-modified lncRNA H19: a new mechanism for Jianpi Qingre Tongluo Prescription in repressing inflammation and improving lipid metabolism in gout arthritis

Crossref DOI link: https://doi.org/10.1186/s13020-026-01379-z

Published Online: 2026-03-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Xianheng

Liu, Jian

Chen, Xiaolu

Ding, Xiang

Liu, Shengfeng

Cheng, Xueni

Fang, Dahai
Funding

Funding for this research was provided by:

High Level Key Disciplines of Traditional Chinese Medicine under the State Administration of Traditional Chinese Medicine (ZYYZDXK-2023100)

Project on Enhancing Clinical Evidence-Based Capacity for Treating Advantageous Diseases in Traditional Chinese Medicine (Wan Cai She [2024] No. 1359)

12th batch of ‘115’ Innovation team of Anhui Province (Anhui Talent Office [2019] No. 1)
License Information

Text and Data Mining valid from 2026-03-18

Version of Record valid from 2026-03-18
More Information

Article History

Received: 25 September 2025

Accepted: 11 March 2026

First Online: 18 March 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below